Search is Powered by Google
Cancer / Oncology News

Exercise And Rest Reduce Cancer Risk

Main Category: Cancer / Oncology
Also Included In: Public Health
Article Date: 18 Nov 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Exercise is good for more than just your waistline. A recent study presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research suggests that regular physical activity can lower a woman's overall risk of cancer but only if she gets a good night's sleep. Otherwise, lack of sleep can undermine exercise's cancer prevention benefits.

"Greater participation in physical activity has consistently been associated with reduced risk of cancer incidence at several sites, including breast and colon cancers," said James McClain, Ph.D., cancer prevention fellow at the National Cancer Institute and lead author of the study. "Short duration sleep appears to have opposing effects of physical activity on several key hormonal and metabolic parameters, which is why we looked at how it affected the exercise/cancer risk relationship."

Even though the exact mechanism of how exercise reduces cancer risk isn't known, researchers believe that physical activity's effects on factors including hormone levels, immune function, and body weight may play an important role. The study examined the link between exercise and cancer risk, paying special attention to whether or not getting adequate sleep further affected a women's cancer risk.

Researchers assessed the association between physical activity energy expenditure (PAEE), sleep duration and incidence of overall, breast, and colon cancer in 5,968 women at least 18 years old with no previous cancer diagnoses. The women completed an initial survey in 1998 and were then tracked through the Washington County Cancer Registry and Maryland State Cancer Registry for nearly 10 years.

The results pointed to a sleep-exercise link. "Current findings suggest that sleep duration modifies the relationship between physical activity and all-site cancer risk among young and middle-aged women," he said.

Out of those 5,968 women, 604 experienced a first incidence of cancer, including 186 breast cancer cases. Women in the upper 50 percent of PAEE showed significantly reduced risk of overall cancer and breast cancer. Among women 65 or younger when surveyed and in the upper half of PAEE, sleeping less than seven hours a day increased overall cancer risk, negating much of the protective effects of physical activity on cancer risk for this group.

The next step, says McClain, would be to confirm current findings and investigate potential mechanisms underlying the interaction between sleep and exercise in order to better understand their roles in cancer prevention.

Research is expanding rapidly on the effect of insufficient and prolonged sleep duration on many health outcomes although few studies have examined the association of sleep duration with cancer risk. This novel study examining the interaction of sleep and physical activity suggests another future focus of research on health behaviors and cancer outcomes.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and 80 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. The AACR's most recent publication and its sixth major journal, Cancer Prevention Research, is dedicated exclusively to cancer prevention, from preclinical research to clinical trials. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.

American Association for Cancer Research (AACR)
615 Chestnut St., 17th Fl.
Philadelphia
PA 19106
United States
http://www.aacr.org




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...